Skip to main content
TYK Medicines, Inc logo

TYK Medicines, Inc — Investor Relations & Filings

Ticker · 2410 ISIN · CNE100006L34 HKEX Manufacturing
Open in API
Filings indexed 871 across all filing types
Latest filing 2022-09-02 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2410

About TYK Medicines, Inc

https://www.tykmedicines.com

TYK Medicines, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery, development, and commercialization of innovative small-molecule targeted therapies. The company leverages a proprietary small molecule drug design and screening platform, with a primary strategic focus on oncology, particularly treatments for lung cancer. The lead pipeline asset, TY-9591 (Edotamidine mesylate), an EGFR-targeted therapy, is currently in the Pre-NDA stage, having demonstrated promising clinical efficacy in treating lung cancer patients with brain metastasis. The pipeline also includes assets such as TY-302 and TY-2136, alongside multiple CDK inhibitors in clinical development, reflecting a commitment to addressing unmet medical needs in targeted cancer treatment.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return for Equity Issuer and Hong Kong Depositary Receipts listed under Chapter 19B of the Exchange Listing Rules on Movements in Securities' for the month ended 31 August 2022. It details movements in issued shares, confirms compliance with listing rules, and provides information about share capital and securities movements. It is a regulatory submission to the Hong Kong Exchanges and Clearing Limited, reporting share capital and securities movements for a specific month. The document is not a financial report, earnings release, or management discussion, nor is it an announcement of voting results or a proxy statement. It is a regulatory filing related to securities movements and confirmations under exchange rules. Therefore, it fits best under Regulatory Filings (RNS). The document length (5561 characters) and content confirm it is a substantive regulatory report rather than a brief announcement or certification only.
2022-09-02 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022
Interim / Quarterly Report Classification · 100% confidence The document is titled 'INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2022' and contains detailed unaudited condensed consolidated financial information including statements of profit or loss, comprehensive income, financial position, notes on accounting policies, segment information, and other financial disclosures. The period covered is six months ending 30 June 2022, which is a typical interim or quarterly reporting period. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement or certification. The content aligns with an Interim / Quarterly Report as it provides substantive financial data and analysis for a period shorter than a full fiscal year. Therefore, the appropriate classification is Interim / Quarterly Report (IR). H1 2022
2022-08-26 English
DATE OF BOARD MEETING
Regulatory Filings Classification · 95% confidence The document is a short announcement from Namyue Holdings Limited stating the date of a board meeting to consider and approve the unaudited interim results for the six months ended 30 June 2022. It does not contain any financial data or the actual interim report, but merely announces the upcoming board meeting related to interim results. The document length is only 1341 characters, which is quite short and fits the pattern of an announcement rather than a full report. According to the rules, such announcements about meetings to approve interim results are best classified as Regulatory Filings (RNS) because they do not contain substantive financial data or the report itself.
2022-08-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
Regulatory Filings Classification · 95% confidence The document is a monthly return report for movements in securities, specifically for Namyue Holdings Limited, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in issued shares, confirms compliance with listing rules, and provides information about share capital and securities issued. The document is structured as a regulatory return rather than a financial report, earnings release, or management discussion. It does not contain financial statements or detailed financial analysis but serves as a regulatory filing to report share capital movements and confirmations. Therefore, it fits best under the category of Regulatory Filings (RNS). The document length and content confirm it is not merely an announcement but a formal regulatory submission.
2022-08-01 English
AMENDED ARTICLES OF ASSOCIATION
Governance Information Classification · 95% confidence The document is titled 'Articles of Association' for Namyue Holdings Limited, adopted by a special resolution. It contains detailed company governance rules, definitions, share rights, registered office, and procedural articles. It is a foundational governance document outlining the internal rules and structure of the company rather than financial results, management changes, or meeting announcements. There is no indication of financial data, audit information, or meeting materials. The content aligns with governance information about company structure and rules. Therefore, the document fits the category of Governance Information (CGR). The document length is substantial and contains the full articles, not just an announcement or summary, so it is not a report publication announcement or regulatory filing.
2022-07-29 English
CHANGE OF COMPANY NAME, AMENDMENTS TO THE ARTICLES OF ASSOCIATION, CHANGE OF STOCK SHORT NAME, CHANGE OF COMPANY LOGO AND CHANGE OF COMPANY WEBSITE
Board/Management Information Classification · 95% confidence The document is an announcement from Namyue Holdings Limited regarding changes to the company name, amendments to the articles of association, change of stock short name, company logo, and company website. It details the effective dates of these changes and references shareholder approval at an extraordinary general meeting (EGM). The document does not contain financial statements, audit information, or detailed financial data. It is not a report but an official announcement of corporate changes. This fits the category of Board/Management Information (MANG), which includes announcements of changes in company details and management-related corporate actions. The document length is 5632 characters, sufficient for a detailed announcement but not a full report. Therefore, the appropriate classification is MANG with high confidence.
2022-07-29 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.